Visfatin: a new player in mesangial cell physiology and diabetic nephropathy

American Journal of Physiology - Renal Physiology - Tập 295 Số 5 - Trang F1485-F1494 - 2008
Hye Kyoung Song1, Mihwa Lee, Bo Kyung Kim, Yun Gyu Park, Gang Jee Ko, Young Sun Kang, Jee‐Young Han, Sang Youb Han, Kum Hyun Han, Hyoung Kyu Kim, Dae Ryong
1Department of Internal Medicine, Korea University, Ansan City, Kyungki-Do, Korea.

Tóm tắt

Visfatin is an adipocytokine that improves insulin resistance and has an antidiabetic effect. However, the role of visfatin in the kidney has not yet been reported. In this experiment, the synthesis and physiological action of visfatin in cultured mesangial cells (MCs) were studied to investigate the role of visfatin in diabetic nephropathy. Visfatin was found synthesized in MCs as well as adipocytes. Visfatin synthesis was markedly increased, not by angiotensin II, but by high glucose stimuli. In addition, visfatin treatment induced a rapid uptake of glucose, peaking at 20 min after visfatin treatment in a dose-dependent manner. A small inhibiting RNA against insulin receptor significantly blocked visfatin-mediated glucose uptake. Visfatin stimuli also enhanced intracellular NAD levels, and treatment with FK866, which is a specific inhibitor of nicotinamide phosphoribosyltransferase (Nampt), significantly inhibited visfatin-induced NAD synthesis and glucose uptake. Visfatin treatment increased glucose transporter-1 (GLUT-1) protein expression in isolated cellular membranes, and pretreatment with cytochalasin B completely inhibited visfatin-induced glucose uptake. Moreover, immunofluorescent microscopy showed the migration of cytosolic GLUT-1 into cellular membranes after visfatin treatment. In accordance with these results, the activation of protein kinase B was detected after visfatin treatment. Furthermore, visfatin treatment dramatically increased the synthesis of profibrotic molecules including transforming growth factor-β1, plasminogen activator inhibitor-1, and type I collagen, and pretreatment with cytochalasin B completely inhibited visfatin-induced upregulation of profibrotic molecules. These results suggest that visfatin is produced in MCs, which are a novel target for visfatin, and play an important role in the pathogenesis of diabetic nephropathy.

Từ khóa


Tài liệu tham khảo

10.1016/S1043-2760(00)00301-5

Ayo S, Radnik R, Garoni J, Glass W, Kreisberg J. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339–1348, 1990.

10.1152/ajprenal.1991.261.4.F571

10.1152/ajprenal.1991.260.2.F185

10.1053/j.ajkd.2006.11.021

10.2337/diabetes.54.10.2911

10.1002/art.22833

10.1210/jc.2005-1475

10.1172/JCI114066

10.1161/CIRCULATIONAHA.106.665893

10.1056/NEJM199309303291401

10.1126/science.1097243

10.1007/s00125-006-0303-7

10.1210/jc.2005-2248

10.1007/BF00418276

Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436–7442, 2003.

10.1172/JCI118226

Heilig C, Zaloga C, Lee M, Zhao X, Riser B, Brosius F, Cortes P. Immunogold localization of high affinity glucose transporter isoforms in normal rat kidney. Lab Invest 73: 674–684, 1995.

10.1126/science.7678183

10.1046/j.1523-1755.1999.00438.x

Kikkwa R, Kajiwara N, Haneda M, Shigeta Y, Tsuda K, Yano H, Seino Y. GLUT1 is the main glucose transporter in rat mesangial cells (Abstract). J Am Soc Nephrol 3: 830, 1992.

10.2337/diab.36.2.240

10.1016/j.bbrc.2007.03.105

10.1016/j.bbrc.2005.05.058

10.1038/ki.1994.249

10.1111/j.1365-2265.2007.02966.x

10.1111/j.1462-8902.2004.00334.x

10.1016/j.cmet.2007.09.003

10.1128/MCB.14.2.1431

10.1016/j.metabol.2006.12.005

Sochor M, Maquer NZ, Hothersall JS, Mclean P. Effect of experimental diabetes on the activity of hexokinase isoenzymes in tissues of the rat. Biochem Int 22: 467–474, 1990.

10.1210/en.2004-0610

10.2337/diab.42.1.118

10.1016/j.metabol.2006.12.001

10.1210/jc.2006-1303

10.1007/BF00400633

10.1172/JCI200319246

10.1152/ajprenal.1991.260.1.F138

10.1038/ki.1992.330

Thông tin
Thông tin xuất bản

American Journal of Physiology - Renal Physiology

Tập 295 Số 5

F1485-F1494

Thông tin tác giả